ALDX:NASDAQ
Aldeyra Therapeutics Inc
$1.46
arrow_downward
-2.67%(-0.040) 1D
$1.48
arrow_upward
+1.37% (+0.020)bedtimeAfter hours
Closed: Sep 10, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALDX...
Open
$1.48
High
$1.50
Low
$1.46
Mkt. cap
88.08M
Avg. vol.
708.42K
Volume
0.00
52-wk high
$5.93
52-wk low
$1.07
EPS
-$0.38
Beta
1.20
Shares outstanding
60.33M
No. of employees
6
Open
$1.48
High
$1.50
Low
$1.46
Mkt. cap
88.08M
Avg. vol.
708.42K
Volume
0.00
52-wk high
$5.93
52-wk low
$1.07
EPS
-$0.38
Beta
1.20
Shares outstanding
60.33M
No. of employees
6
News stories
From web sources and news partners
Zacks
·
12 hours ago
Bayer Secures FDA Nod for Sevabertinib's First-Line Use in NSCLC
About Aldeyra Therapeutics Inc
CEOTodd C. Brady M.D., Ph.D.
Employees6
Founded2004
HeadquartersLexington, Massachusetts, United States
SectorBiotechnology
Websitealdeyra.com